South Korea
· Delayed Price · Currency is KRW Theragen Etex Co.,Ltd. Statistics
Total Valuation
Theragen Etex Co.,Ltd. has a market cap or net worth of KRW 109.62 billion. The enterprise value is 145.37 billion.
| Market Cap | 109.62B |
| Enterprise Value | 145.37B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Theragen Etex Co.,Ltd. has 32.01 million shares outstanding. The number of shares has increased by 1.32% in one year.
| Shares Outstanding | 32.01M |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 9.88% |
| Owned by Institutions (%) | 1.19% |
| Float | 26.34M |
Valuation Ratios
The trailing PE ratio is 4.02.
| PE Ratio | 4.02 |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| PB Ratio | 0.68 |
| P/FCF Ratio | 80.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.65, with an EV/FCF ratio of 106.38.
| EV / Earnings | 5.47 |
| EV / Sales | 0.60 |
| EV / EBITDA | 7.65 |
| EV / EBIT | 11.26 |
| EV / FCF | 106.38 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 23.12.
| Current Ratio | 1.31 |
| Quick Ratio | 0.94 |
| Debt / Equity | 23.12 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | 30.69 |
| Interest Coverage | 5.42 |
Financial Efficiency
Return on equity (ROE) is 17.79% and return on invested capital (ROIC) is 4.19%.
| Return on Equity (ROE) | 17.79% |
| Return on Assets (ROA) | 3.20% |
| Return on Capital (ROIC) | 4.19% |
| Revenue Per Employee | 1.20B |
| Profits Per Employee | 131.63M |
| Employee Count | 202 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 4.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.81% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -27.81% |
| 50-Day Moving Average | 3,762.40 |
| 200-Day Moving Average | 4,023.00 |
| Relative Strength Index (RSI) | 39.82 |
| Average Volume (20 Days) | 72,405 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Theragen Etex Co.,Ltd. had revenue of KRW 241.95 billion and earned 26.59 billion in profits. Earnings per share was 825.72.
| Revenue | 241.95B |
| Gross Profit | 118.17B |
| Operating Income | 13.81B |
| Pretax Income | 32.38B |
| Net Income | 26.59B |
| EBITDA | 19.89B |
| EBIT | 13.81B |
| Earnings Per Share (EPS) | 825.72 |
Balance Sheet
The company has 25.53 billion in cash and 41.94 billion in debt, giving a net cash position of -16.41 billion or -512.78 per share.
| Cash & Cash Equivalents | 25.53B |
| Total Debt | 41.94B |
| Net Cash | -16.41B |
| Net Cash Per Share | -512.78 |
| Equity (Book Value) | 181.43B |
| Book Value Per Share | 5,064.45 |
| Working Capital | 29.93B |
Cash Flow
In the last 12 months, operating cash flow was 8.04 billion and capital expenditures -6.67 billion, giving a free cash flow of 1.37 billion.
| Operating Cash Flow | 8.04B |
| Capital Expenditures | -6.67B |
| Free Cash Flow | 1.37B |
| FCF Per Share | 42.70 |
Margins
Gross margin is 48.84%, with operating and profit margins of 5.71% and 10.99%.
| Gross Margin | 48.84% |
| Operating Margin | 5.71% |
| Pretax Margin | 13.38% |
| Profit Margin | 10.99% |
| EBITDA Margin | 8.22% |
| EBIT Margin | 5.71% |
| FCF Margin | 0.56% |
Dividends & Yields
Theragen Etex Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.37% |
| Buyback Yield | -1.32% |
| Shareholder Yield | -1.32% |
| Earnings Yield | 24.11% |
| FCF Yield | 1.25% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |